| Quote | Spy BMY NEW ![]() |
Message Board | |||||
|
Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders. |
|
Four Healthcare Stocks On Fire
BMY EXEL ISRG NVS SNY WCG Linked by Investopedia Stock Analysis - November 18, 05:13PM from (stocks.investopedia.com) Fourth healthcare stocks that have brushed aside any potential adversity that could arise from future legislation for the more ...
Breakingviews.com: This Poison Pill Aids Investors
BMY Linked by NYTimes - November 17, 11:39PM from (feeds.nytimes.com) Mead, a maker of baby formula, should make a tasty target for several food companies. But the technicalities of Mead’s more ...
FDA: Thin Blood, Sour Stomach
BMY AZN SNY Linked by 24/7 Wall St. - November 17, 11:37AM from (247wallst.com) The FDA is routinely criticized for being a poor steward of drug research and pharmaceutical side effects. The agency proved more ...
Bristol Myers Price Target, Earnings Estimate Raised at Barclays Capital
BMY Linked by The Dividend Daily - November 17, 09:10AM from (www.dividend.com) Pharmaceutical products maker Bristol Myers Squibb Co. (BMY) saw its price target and earnings estimate boosted on Tuesday by analysts at Barclays Capital. more ...
Breakingviews.com: Bristol Exchange Eases Downsizing
BMY JPM Linked by NYTimes - November 16, 07:58PM from (feeds.nytimes.com) A drug maker’s stock swap plan will make its decline less painful for investors, but will not reverse it. more ...
Market Wrap-Up for Nov.16
BA BMY ETN EMR LOW NTRS STT BHP RTP X GLD USO BLK MJN TLT Linked by The Dividend Daily - November 16, 04:10PM from (www.dividend.com) The market is learning to like Mondays, with another triple-digit gain for the second week in a row. As for today's more ...
Bristol Myers Spinning off Mead Johnson Nutrition
BMY Linked by The Dividend Daily - November 16, 10:38AM from (www.dividend.com) Pharmaceuticals maker Bristol Myers Squibb Co. (BMY) on Monday said it is completing its spin-off of baby formula maker Mead Johnson Nutrition Co. more ...
Bristol-Myers Cleans Up on Mead Johnson
BMY MJN Linked by 24/7 Wall St. - November 16, 09:29AM from (247wallst.com) Bristol-Myers Squibb Company (NYSE: BMY) is going to completely separate itself from its holdings in Mead Johnson Nutrition more ...
Media Digest 11/16/2009 Reuters, WSJ, NYTimes, FT, Bloomberg
BMY GE WPO C PALM UBS CMCSA GOOG LVS BLK Linked by 24/7 Wall St. - November 16, 04:00AM from (247wallst.com) Reuters: The Ohio Attorney General is suing a number of Wall St. firms. Reuters: GM will start to repay part of its debt to the US. more ...
Bristol-Myers Squibb Announces Split-Off of Mead Johnson
BMY Linked by BusinessWire - November 15, 07:00PM from (www.businesswire.com) Bristol-Myers Squibb Company (NYSE: BMY) today announced it will split off its holdings in Mead Johnson Nutrition Company. more ...
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | About | Register | My tickerspy | Logout | Web site design by LightMix |
| © 2009 Indie Research, LLC. All rights reserved. | |
---
Institutional Holdings Disclaimer Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter. Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time. tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors. THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF. |
|